Search

Presentations

EHA-TSH Hematology Tutorial on T Cell LymphomasSession 1: New classification and epidemiology of T cell diseases

Lecture: V Tabanelli (here)
Session 2: How I treat PTCL NOS patients

Lecture: E Birtaş Ateşoğlu (here)
Clinical Case: E Kırcalı (here)
Self-assessment Case: E Birtaş Ateşoğlu (here)
Session 3: First line treatment of…

Highlights from the SWG

EHA2023 CongressThe EHA2023 Congress was held in Frankfurt, Germany, in June 2023. Guideline sessionTitle‘The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children.

EHA-ASH Translational Research Training in Hematology

TRTH 2025 call is now closed. What is Translational Research Training in Hematology?Translational Research Training in Hematology (TRTH) provides early-career researchers with a unique, year-long training and mentoring experience.

Presentations

EHA-GBMTA-AHA Hematology Tutorial

Session 1: Indolent Non-Hodgkin Lymphoma

Lecture: M Gomes da Silva
Clinical Case: M Kurtsadze
Self-assessment Cases: M Gomes da Silva
Session 2: Aggressive Non-Hodgkin Lymphoma

Lecture: K Polgárová
Clinical Case: G Saghumyan
Self-assessment Cases: K Polgárová
Session 3: Myeloproliferative neoplasms (MPN)

Lecture: P Harrington
Clinical Case: K Meliksetyan
Self-assessment Cases: P Harrington
Session 4: Hodgkin Disease

Lecture: I Aurer
Clinical Case: M Zarandia
Self-assessment…

Promising results in trials with non-chemotherapy treatments for Leukemias to be presented at the 18th Congress of the European Hematology Association in Stockholm, June 13-16, 2013

Mar 28 2013 Posted in Press releases

What is new? Current investigations are aimed at evaluating the use of monoclonal antibodies (mAB). These mABs bind to specific molecules (antigens) found on leukemic cells. This results in immune destruction of the leukemic cells.

FP9 recommendations BioMed Alliance

Apr 10 2018 Posted in Advocacy news

With preparations under way for the EU’s next Framework Programme for Research and Innovation (FP9), the BioMed Alliance has called for more robust EU support for health research.

Major research funding calls are out now

Dec 12 2013 Posted in Advocacy news

First, the Innovative Medicines Initiative published its final call under the EU Seventh Framework Programme. Interestingly for hematologists, the call includes a project called ‘Blood-based biomarker assays for personalized tumour therapy: value of circulating biomarkers’.

Guidelines endorsed by EHA

EHA will not accept endorsement requests until the end of 2025.

EHA policy on double awarding

EHA is guided by the concept of supporting as many young investigators/clinicians as possible in their career development. Therefore, double awarding is not allowed. Winning an award excludes the award winner from winning another award while receiving the first.